IASLC PRESS ROOM - 2012

Februrary

• Using online patient communities and new trial approaches to optimize clinical research (Feb. 15, 2012)

January

• The link between TB and a gene mutation that causes lung cancer (Jan. 15, 2012)

• Estrogen-targeting drug combo may help prevent lung cancer (Jan. 10, 2012)

• AACR-IASLC Joint Conference to focus on new diagnostic techniques, potential treatments (Jan. 5, 2012)

2011

December

• IASLC sets up committee to move CT lung cancer strategic screening forward (Dec. 15, 2011)

September

• Lung cancer ALK rearrangement may predict pemetrexed efficacy, study shows (Sept. 1, 2011)
• Fibrous stroma associated with poor prognosis in lung squamous cell carcinoma (Sept. 1, 2011)

August

• Study: Inexpensive method detects ALK rearrangement in lung cancer patients (Aug. 2, 2011)

July

• Amrubicin improved response rate and progression-free survival vs. topotecan in Phase III trial (July 4, 2011)
• TEMLA shows higher diagnostic yield than EBUS or EUS in largest reported series to date (July 4, 2011)
• Lung tumors in never smokers show greater genomic instability than those in smokers (July 4, 2011)
• ALK rearrangement found in nearly 10% of patients in Lung Cancer Mutation Consortium (July 4, 2011)
• EURTAC Phase III study: Erlotinib nearly doubles progression-free survival v. chemotherapy (July 4, 2011)
• High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy (July 4, 2011)
• Endosonography followed by surgical staging improves quality of life, according to ASTER study (July 6, 2011)
• Increased investment in thoracic surgical expertise increased UK lung cancer resection rate (July 6, 2011)
• Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009 (July 6, 2011)
• PET scan with [11C] erlotinib may provide non-invasive method to identify TKI-responsive lung tumors (July 6, 2011)
• Cancer patients with blood clots gain no benefit from addition of a vena cava filter to treatment with fondaparinux (July 7, 2011)
• Women, elderly and minorities poorly represented in lung cancer drug trial data submitted to U.S. FDA (July 7, 2011)
• Canada's Cancer Risk Management (CRM) model is an important new health tool for policymakers (July 7, 2011)

June

• IASLC launches Staging Atlas in Thoracic Oncology for iPad, iPhone, Android and BlackBerry (June 1, 2011)
• Five advocacy organizations win travel awards to attend World Conference on Lung Cancer in Amsterdam  (June 1, 2011)
• Asian lung cancer patient survival exceeds Caucasians' on multiple regimens (June 10, 2011)

May

• Renal cancer drug temsirolimus shows promise against mesothelioma (May 1, 2011)

April

• New lung cancer staging system (TNM 7) better predicts local/regional recurrence, study shows (April 1, 2011)

March

• Soy increases radiation's ability to kill lung cancer cells, study showsSpontaneous smoking cessation may be an early symptom of lung cancer, research suggests (March 1, 2011)
• Lymph node dissection is not essential in small screen-detected lung cancers, new research shows (March 1, 2011)
• IASLC to help advocacy organizations attend 14th World Conference on Lung Cancer in Amsterdam (March 4, 2011)

February

• High levels of circulating DNA may signal faster progression of lung cancer (Feb. 1, 2011)
• Top lung societies unveil new international classification of lung adenocarcinoma (Feb. 1, 2011)

January

• Study finds evidence of increased lung cancer risk among tuberculosis patients (Jan. 1, 2011)
• Online registration opens for 14th World Conference on Lung Cancer in Amsterdam (Jan. 4, 2011)

 

 2010

November

• Research explores lung cancer among pediatric cancer patients (Nov. 1, 2010)

October

• TRUST study data confirms safety and efficacy of erlotinib for advanced lung cancer (Oct. 1, 2010)
• New lung cancer research finds half of advanced lung cancer patients receive chemotherapy (Oct. 1, 2010)

September

• Tumor budding identified as predictor for unfavorable outcome in lung cancer (Sept. 1, 2010)
• Lung cancer survival rates improved through use of individualized chemotherapy (Sept. 1, 2010)

August

• Research defines timeframes, factors to deem early stage lung cancer cured (Aug. 2, 2010)
• Lung cancer survivors experience long-term effects of breathlessness (Aug. 2, 2010)

July

• New method of tissue banking makes gene analysis more practical for lung cancer (July 15, 2010)

June

• Novel paclitaxel formulation encouraging for treating advanced lung cancer (June 15, 2010)
• Lung cancer research concludes that early diagnosis is key for improving survival (June 15, 2010)

May

• 2nd European Lung Cancer Conference press program (May 1, 2010)
• Research identifies patterns of CD24, a novel biomarker for non-small cell lung carcinomas (May 5, 2010)

April

• Discover why this is a critical moment for lung cancer research (April 15, 2010)
• Study shows partial lung removal favorable over full removal as treatment for lung cancer (April 1, 2010)

March

• Lung cancer research explores the effects of patient attitudes on patient outcomes (March 3, 2010)
• Patient age not a factor in use of second-line therapy for lung cancer (March 3, 2010)